Ireland
--:--IST
Latest
Clinical Trials in France / NCT07532811
Recruiting Not applicable

Evaluation of Perfusion and Ventilation Distribution in Children: a Pilot Study.

NCT07532811 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-05-13
Last updated
2026-05-19

Condition(s) studied

Acute Respiratory Failure

Investigational drug(s) / intervention(s)

Evaluation of perfusion with Electrical impedance tomography using sodium chloride or sodium bicarbonate

Evaluation of perfusion with Electrical impedance tomography using sodium chloride or sodium bicarbonate: All patients will undergo EIT monitoring (Enlight 2100, Timpel, Brazil) using a belt adjusted to the thoracic circumference. Ventilation distribution will be assessed with a tidal volume of 8 mL/kg. Following a breath hold, a saline solution (sodium chloride or sodium bicarbonate) will be injected over a few seconds. Perfusion distribution, as well as impedance signal variation, will be recorded using dedicated software (Timpel, Brazil). Data acquisition will be considered valid if the impedance signal variation induced by the saline solution injection is at least equivalent to the amplitude variation observed during ventilation with a tidal volume of 8 mL/kg. 2 measurements at 4 to 6-hours intervals with volume or concentration adjustment after the first injection if needed in the group 1

Study summary

Electrical impedance tomography (EIT) is a recent monitoring technique that provides information on regional ventilation distribution. Following the injection of a hypertonic saline bolus, EIT can also assess regional pulmonary perfusion distribution, allowing evaluation of the ventilation/perfusion (V/Q) ratio.

In adults, protocols for assessing perfusion distribution require the injection of 10 mL of a 7.5% or 10% NaCl solution or sodium bicarbonate over a few seconds. Studies have reported good hemodynamic tolerance, adequate image quality, and no significant changes in serum sodium levels. However, this volume and sodium load are not appropriate for small children.

To date, no pediatric protocol exists for assessing pulmonary perfusion distribution and the ventilation/perfusion ratio using EIT. It is therefore proposed to conduct a pilot study to evaluate the feasibility of assessing pulmonary perfusion by EIT using a weight-adjusted bolus of hypertonic saline (NaCl or sodium bicarbonate).

Eligibility

Sex
ALL
Min age
—
Max age
12 Years
Healthy volunteers
No
Inclusion Criteria: * patients \< 12 years hospitalized in pediatric intensive care * intubated, under conventional invasive mechanical ventilation and sedated * between 3 and 40 kg * with central venous access in the superior vena cava * consent signed by parents or legal guardians Exclusion Criteria: * Patients with significant leaks \> 20% around the endotracheal tube * Patients receiving spontaneous ventilation (inspiratory support, NIV, etc.) * Natremia \> 150 mmol/L at inclusion * Hyperchloremia ≥ 115 mmol/L and/or hypokaliema ≤ 3 mmol/L * Patients with intracranial hypertension * Patients with active bleeding or persistent hemodynamic instability despite amines * Patients with heart failure, uncorrected cyanotic heart disease, or a history of cardiac arrhythmia * Patients with contraindications to the use of the electrical impedance pulmonary tomography belt (skin lesions, burns, or recent thoracic surgery) * Conditions in which EIT data acquisition will be disrupted (chest dressings, pneumothorax, ECMO) * Patients with severe hypoxemia defined as FiO2 \> 90% to maintain SpO2 \> 88% * Individuals not affiliated with a social security system or beneficiaries of a similar system

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Florent BAUDIN Bron France Recruiting

More Hospices Civils de Lyon trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07532811 on ClinicalTrials.gov ↗ ← All trials in France